252 related articles for article (PubMed ID: 33436953)
1. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study.
Kakiuchi T; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Okuda M
Sci Rep; 2021 Jan; 11(1):755. PubMed ID: 33436953
[TBL] [Abstract][Full Text] [Related]
2. Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
Horii T; Suzuki S; Takano C; Shibuya H; Ichijima R; Kusano C; Ikehara H; Gotoda T
J Gastroenterol Hepatol; 2021 Dec; 36(12):3314-3321. PubMed ID: 34107551
[TBL] [Abstract][Full Text] [Related]
3. Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.
Kakiuchi T; Mizoe A; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Nakayama A; Okuda M; Matsuo M
Helicobacter; 2020 Jun; 25(3):e12690. PubMed ID: 32207209
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
[TBL] [Abstract][Full Text] [Related]
5. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
Ozaki H; Harada S; Takeuchi T; Kawaguchi S; Takahashi Y; Kojima Y; Ota K; Hongo Y; Ashida K; Sakaguchi M; Tokioka S; Sakamoto H; Furuta T; Tominaga K; Higuchi K
Digestion; 2018; 97(3):212-218. PubMed ID: 29393194
[TBL] [Abstract][Full Text] [Related]
6. Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for
Hu Y; Xu X; Ouyang YB; He C; Li NS; Xie C; Peng C; Zhu ZH; Shu X; Xie Y; Lu NH; Zhu Y
Front Cell Infect Microbiol; 2022; 12():881968. PubMed ID: 35719338
[TBL] [Abstract][Full Text] [Related]
7. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
[TBL] [Abstract][Full Text] [Related]
8. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota.
Cui MY; Cui ZY; Zhao MQ; Zhang MJ; Jiang QL; Wang JJ; Lu LG; Lu YY
BMC Microbiol; 2022 Dec; 22(1):321. PubMed ID: 36581836
[TBL] [Abstract][Full Text] [Related]
9. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
[TBL] [Abstract][Full Text] [Related]
10. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
Chen J; Zhang Y; Min H; Zhi J; Ma S; Dong H; Yan J; Chi X; Zhang X; Yang Y
Helicobacter; 2024; 29(2):e13077. PubMed ID: 38682268
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.
Gotoda T; Takano C; Kusano C; Suzuki S; Ikehara H; Hayakawa S; Andoh A
Helicobacter; 2018 Dec; 23(6):e12541. PubMed ID: 30311721
[TBL] [Abstract][Full Text] [Related]
13. Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis.
Ye Q; Shao X; Shen R; Chen D; Shen J
Helicobacter; 2020 Aug; 25(4):e12713. PubMed ID: 32515529
[TBL] [Abstract][Full Text] [Related]
14. Comparative study: Vonoprazan and proton pump inhibitors in
Sakurai K; Suda H; Ido Y; Takeichi T; Okuda A; Hasuda K; Hattori M
World J Gastroenterol; 2017 Jan; 23(4):668-675. PubMed ID: 28216974
[TBL] [Abstract][Full Text] [Related]
15. Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes.
Suzuki S; Gotoda T; Takano C; Horii T; Sugita T; Ogura K; Ichijima R; Kusano C; Ikehara H
Helicobacter; 2021 Dec; 26(6):e12851. PubMed ID: 34486195
[TBL] [Abstract][Full Text] [Related]
16. Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication.
Hu Y; Xu X; Ouyang YB; He C; Li NS; Xie C; Peng C; Zhu ZH; Xie Y; Shu X; Lu NH; Zhu Y
Helicobacter; 2022 Oct; 27(5):e12923. PubMed ID: 36036087
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Vonoprazan for Helicobacter pylori Eradication.
Kiyotoki S; Nishikawa J; Sakaida I
Intern Med; 2020 Jan; 59(2):153-161. PubMed ID: 31243237
[TBL] [Abstract][Full Text] [Related]
18. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
[TBL] [Abstract][Full Text] [Related]
19. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study.
Hirata Y; Yamada A; Niikura R; Shichijo S; Hayakawa Y; Koike K
Helicobacter; 2020 Oct; 25(5):e12719. PubMed ID: 32602161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
